Tumor heterogeneity and in vitro chemosensitivity testing in ovarian cancer

American Journal of Obstetrics and Gynecology

Volumn 176, Issue 4, 1997, Pages 759-768

  Sevin, B U ^a   Perras, J P ^a   Curry, S L ^a   Jones III, H W ^a   Herbst, A L ^a  

^a MAYO CLINIC   (United States)

Author keywords

chemosensitivity assay; heterogeneity in drug response; Human ovarian cancer

Indexed keywords

4 HYDROPEROXYCYCLOPHOSPHAMIDE; CARBOPLATIN; CISPLATIN; CYCLOPHOSPHAMIDE DERIVATIVE; PACLITAXEL;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CELL CULTURE; CHEMOSENSITIVITY; CYTOTOXICITY TEST; DRUG SCREENING; HUMAN; HUMAN CELL; OVARY CANCER; PRIORITY JOURNAL;

EID: 0030973444     PISSN: 00029378     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9378(97)70599-4     Document Type: Article

References (19)

1. RF Ozols SC Rubin AJ Dembo S Robboy Epithelial ovarian cancer WJ Hoskins CA Perez RC Young Principles and practice of gynecologic oncology 1992 JB Lippincott Philadelphia 731 781
2. WP McGuire WJ Hoskins MF Brady PR Kucera EE Partridge KY Look Cyclophosphamide and cisplatin compared with paclitaxel and cisplatin in patients with stage III and stage VI ovarian cancer N Engl J Med 334 1996 1 6
3. RC Young Principles of chemotherapy in gynecologic cancer WJ Hoskins CA Perez RC Young Principles and practice of gynecologic oncology 1992 JB Lippincott Philadelphia 333 347
4. LM Weisenthal Predictive assays for drug and radiation resistance JM Masters Human cancer in primary culture: a handbook 1991 (The Netherlands): Kluwer Academic Dordrecht
5. A Hamburger SE Salmon Primary bioassay of human tumor stem cells Science 197 1977 461 463
6. DS Alberts HSG Chen SE Salmon L Young EA Surwit SA Leigh Chemotherapy of ovarian cancer directed by the human tumor stem cell assay Ca Chemother Pharmacol 6 1981 279 285
7. DD Von Hoff GM Clark BJ Stodgill MF Sarosdy MT O'Brien JT Casper Prospective clinical trial of a human tumor cloning system Cancer Res 43 1983 1926 1931
8. SE Salmon JM Trent Human tumor cloning 1984 Grune & Stratton Orlando (FL) 521 534
9. AP Simmonds EC McDonald Ovarian carcinoma cells in culture: assessment of drug sensitivity by clonogenic assay Br J Cancer 50 1984 317 326
10. DD Von Hoff R Kronmal SE Salmon J Turner JB Green JS Bonorris A Southwest Oncology Group study on the use of a human tumor cloning assay for predicting responses in patients with ovarian cancer Cancer 67 1991 20 27
11. BU Sevin ZL Peng JP Perras P Ganjei M Penalver HE Averette Application of an ATP-bioluminescence assay in human tumor chemosensitivity testing Gynecol Oncol 31 1988 191 204
12. BU Sevin JP Perras HE Averette DM Donato MA Penalver Chemosensitivity testing in ovarian cancer Cancer 71 1993 1613 1620
13. OR Koechli B-U Sevin U Haller Chemosensitivity testing in gynecologic malignancies and breast cancer 1994 S. Karger Basel
14. O Koechli BP Avner BU Sevin B Avner JP Perras DS Robinson Application of the adenosine triphosphate-cell viability assay in human breast cancer chemosensitivity testing: a report on first results J Surg Oncol 54 1993 119 125
15. OR Koechli B-U Sevin JP Perras R Angioli A Steren M Rodriguez Growth characteristics of nonmalignant cells in the ATP cell viability assay Oncology 51 1994 35 41
16. TC Chou P Talalay Quantitative analysis of dose-effect relationships: the combined effects of multiple drugs or enzyme inhibitors Adv Enzyme Regul 22 1984 27 55
17. GL Nicholson Molecular mechanisms of cancer metastasis: tumor and host properties and the role of oncogenes and suppressor genes Curr Opin Oncol 3 1991 75 92
18. JR Murren VT DeVita Jr Another look at multidrug resistance Principles Pract Oncol 9 1995 1 12
19. PV Wooley KD Tew Mechanisms of drug resistance in neoplastic cells 1988 Academic San Diego